China has approved stricter controls on the management of human genetic resources. The new requirements, which took effect July 1, follow the international outcry over the handling of genetic materials in China. They mandate that genetic materials are used strictly for scientific... Read More
Seeking new ways to provide healthcare to its aging population while mitigating the impact of soaring healthcare expenses, the Japanese government is adopting a raft of policies to encourage medical innovation. It is promoting the use of artificial intelligence, big data and... Read More
Advances in digital health technologies, from simple access to online medical reports to the ability to conduct surgeries via remote controls, are revolutionizing health care in China. Across the country, surgeons have over the past year manipulated surgical instruments from afar to... Read More
A growing number of Chinese cities are joining its successful bulk drug purchasing program, which has put pressure on pharmaceutical firms to cut prices since it first went into effect last year. That is likely to decrease market share for individual firms,... Read More
Thailand’s Food and Drug Administration is tightening requirements and raising fees for the registration of new drugs. The changes were published in Thailand’s Government Gazette in April as Drug Act (No. 6) B.E. 2562 and go into effect in October, 2019. They... Read More
Seeking to bolster enforcement of its pharmaceuticals market while still accelerating the entrance of innovative drugs and vaccines, the Chinese government has drafted structural changes to its drug and vaccine standards. The draft changes to the Drug Administration Law and the Vaccine... Read More
As a shortage of hospitals, an aging population and a dearth of healthcare workers take a toll on the quality of healthcare in Taiwan, the country is increasingly turning to smart technology, including artificial intelligence, to help route adequate health options to... Read More
In a move certain to escalate tensions between South Korea and the pharmaceutical industry, the government is planning steps designed to lower the prices it pays for drugs under its universal health insurance system. Under the new plan, the government will reevaluate... Read More
Local representatives of foreign medical products firms in Hong Kong will be required to strengthen their procedures for handling, storing and delivering medical devices under new guidelines being proposed by the government. The draft rules on local responsible persons (LRPs), who serve... Read More
As the number of diabetes patients continues to rise in China, so does the prevalence of end-stage kidney disease—and the demand for dialysis treatment. According to a report released in April by the National Institute of Health Data Science at Peking University,... Read More